Thurston, L., Hunjan, T., Mills, E
Related: Stopping GLP-1 Drugs Triggers Weight Regain 4x Faster Than Ending Exercise "It's very common for pharmaceutical companies to collect genetic data on their participants," says Gloyn
Semaglutide may cause serious side effects, including: Thyroid C-Cell Tumors
If a second drug-induced liver injury signal emerges post-marketing on any approved small-molecule GLP-1, the regulatory and commercial framework will recalibrate sharply
Some research protocols account for this by using comparatively lower dosing ranges in female study cohorts, reflecting a generally increased sensitivity to IGF-1 receptor activation a pattern also documented in broader growth hormone axis research, not unique to IGF-1 LR3 specifically